相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol
Qiang-ling Sun et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Protein expression profiling in chemical carcinogenesis: A proteomic-based approach
Simone Schmitz-Spanke et al.
PROTEOMICS (2011)
Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer (Retraction of vol 17, pg v118, 2006)
J. T. Roberts et al.
ANNALS OF ONCOLOGY (2011)
Transcriptional up-regulation of SOD1 by CEBPD: A potential target for cisplatin resistant human urothelial carcinoma cells
Tzyh-Chyuan Hour et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo
Varda Shoshan-Barmatz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2010)
Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: Current status
Victoria C. Hodgkinson et al.
CANCER LETTERS (2010)
Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas
Nozomu Tanji et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2010)
Voltage-dependent Anion Channel 1-based Peptides Interact with Bcl-2 to Prevent Antiapoptotic Activity
Nir Arbel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Identification of proteins responsible for the multiple drug resistance in 5-fluorouracil-induced breast cancer cell using proteomics analysis
Guopei Zheng et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Oligomerization of the Mitochondrial Protein Voltage-Dependent Anion Channel Is Coupled to the Induction of Apoptosis
Nurit Keinan et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
High-throughput generation of selected reaction-monitoring assays for proteins and proteomes
Paola Picotti et al.
NATURE METHODS (2010)
Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines
Zhiqin Dai et al.
PROTEOMICS (2010)
Voltage-dependent Anion Channel 1-based Peptides Interact with Hexokinase to Prevent Its Anti-apoptotic Activity
Laetitia Arzoine et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The VDAC1 N-terminus is essential both for apoptosis and the protective effect of anti-apoptotic proteins
Salah Abu-Hamad et al.
JOURNAL OF CELL SCIENCE (2009)
The crystal structure of the C-terminus of adseverin reveals the actin-binding interface
Sakesit Chumnarnsilpa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Proteome mapping of the Drosophila melanogaster male reproductive system
Nobuaki Takemori et al.
PROTEOMICS (2009)
Hexokinase-2 bound to mitochondria: Cancer's stygian link to the Warburg effect and a pivotal target for effective therapy
Saroj P. Mathupala et al.
SEMINARS IN CANCER BIOLOGY (2009)
Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death
N. Tajeddine et al.
ONCOGENE (2008)
Increased resistance of tumor cells to daunorubicin after transfection of cDNAs coding for anthracycline inactivating enzymes
Mariann Plebuch et al.
CANCER LETTERS (2007)
The role of galectin-3 in cancer drug resistance
Tomoharu Fukumori et al.
DRUG RESISTANCE UPDATES (2007)
Determination of the conformation of the human VDAC1 N-terminal peptide, a protein moiety essential for the functional properties of the pore
Vito De Pinto et al.
CHEMBIOCHEM (2007)
Molecular mechanisms of resistance and toxicity associated with platinating agents
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2007)
Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer
T Fukumori et al.
CANCER RESEARCH (2006)
被撤回的出版物: Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer (Retracted article. See vol. 22, pg. 2536, 2011)
J. T. Roberts et al.
ANNALS OF ONCOLOGY (2006)
Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acouisition of cisplatin resistance in bladder cancer cell lines
T Tsunoda et al.
ONCOGENE (2005)
Oligomeric states of the voltage-dependent anion channel and cytochrome c release from mitochondria
R Zalk et al.
BIOCHEMICAL JOURNAL (2005)
In self-defence: Hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death
H Azoulay-Zohar et al.
BIOCHEMICAL JOURNAL (2004)
A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431
A Castagna et al.
PROTEOMICS (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
Identification of the protein-protein contact site and interaction mode of human VDAC1 with Bcl-2 family proteins
Y Shi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics
J Rappsilber et al.
ANALYTICAL CHEMISTRY (2003)
Is cisplatin-induced cell death always produced by apoptosis?
VM Gonzalez et al.
MOLECULAR PHARMACOLOGY (2001)
VDAC regulation by the Bcl-2 family of proteins
Y Tsujimoto et al.
CELL DEATH AND DIFFERENTIATION (2000)
Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial changes via closing VDAC
H Kusano et al.
ONCOGENE (2000)
Gemcitabine and cisplatin versus methotrexate vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large randomized, multinational, multicenter, phase III study
H von der Maase et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)